SCHEMBL762958

SCHEMBL762958

BC(=C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28679401 0.94
SCHEMBL19229015 0.78
SCHEMBL7955603 0.75
SCHEMBL14124466 0.72
SCHEMBL434958 0.72
SCHEMBL2815 0.72
SCHEMBL6799285 0.72 ALDH1A1 (0.46)
SCHEMBL437564 0.72
SCHEMBL10871026 0.72 ALDH1A1 (0.46)
Hydrochloric Acid SCHEMBL38654278 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 69 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118108669-A Intermediate for preparing EGFR inhibitor and preparation method thereof 苏州浦合医药科技有限公司 2024-05-31 CN claimed
CN-110372469-A Hydrogenate annulus [12] aromatic compound and preparation method thereof 清华大学 2019-10-25 CN claimed
WO-1994003529-A1 HIGH CHAR YIELD SILAZANE DERIVED PRECERAMIC POLYMERS AND CURED COMPOSITIONS THEREOF THE B.F. GOODRICH COMPANY (US) 1994-02-17 WO claimed
US-5256487-A High char yield silazane derived preceramic polymers and cured compositions thereof THE B. F. GOODRICH COMPANY (US) 1993-10-26 US claimed
CN-118108669-A Intermediate for preparing EGFR inhibitor and preparation method thereof 苏州浦合医药科技有限公司 2024-05-31 CN disclosed
EP-3712144-B1 P2X3 AND/OR P2X2/3 RECEPTOR ANTAGONIST, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND USE THEREOF BEIJING TIDE PHARMACEUTICAL CO LTD (CN) 2024-02-14 EP disclosed
CN-116848107-A Compounds and their use as PDE4 activators 米罗尼德有限公司 2023-10-03 CN disclosed
CN-116685318-A Heterocyclic compounds and their use for parasitic diseases 细胞基因公司 2023-09-01 CN disclosed
WO-2023150667-A2 RIBOSE LINKERS AND CONJUGATES THEREOF ELYSIUM HEALTH INC. (US) 2023-08-10 WO disclosed
US-11718614-B2 Compounds and methods for treatment of hedgehog pathway associated conditions SUZHOU MEDNES PHARMA TECH CO., LTD. (CN) 2023-08-08 US disclosed
WO-2023122228-A1 NOVEL AURISTATIN ANALOGS AND IMMUNOCONJUGATES THEREOF ADCENTRX THERAPEUTICS INC. (US) 2023-06-29 WO disclosed
EP-4194226-A1 METHODS OF MANUFACTURING CONJUGATED DIENE-BASED POLYMERS AND THE POLYMERS, RUBBERS AND TIRES MADE THEREFROM TSRC Corporation (TW) 2023-06-14 EP disclosed
WO-2011042145-A1 WNT PATHWAY ANTAGONISTS SIENA BIOTECH S.P.A. (IT) 2011-04-14 WO disclosed
US-7563289-B2 For coloring keratin fibers, human hair CIBA CORPORATION (US) 2009-07-21 US disclosed
US-20090113639-A1 THIOL DYES CIBA CORP. 2009-05-07 US disclosed
WO-2008030332-A1 POLYESTER POLYMER AND COPOLYMER COMPOSITIONS CONTAINING TITANIUM AND YELLOW COLORANTS EASTMAN CHEMICAL COMPANY (US) 2008-03-13 WO disclosed
WO-2008025965-A2 RETINOID COMPOUNDS AND THEIR USE REINNERVATE LIMITED (GB) 2008-03-06 WO disclosed
US-20070032653-A1 N-{1-(4-(3-bromophenyl)-1H-imidazol-2-yl)-5-methylhexyl}-N-cyclohexylamine; agonists or antagonists of somatostatin receptors; acromegaly, restenosis, Crohn's disease, systemic sclerosis, external and internal pancreatic pseudocysts and ascites, nesidoblastosis, hyperinsulinism, gastrinoma, etc. SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES, S.A.S. (FR) 2007-02-08 US disclosed
WO-1994003529-A1 HIGH CHAR YIELD SILAZANE DERIVED PRECERAMIC POLYMERS AND CURED COMPOSITIONS THEREOF THE B.F. GOODRICH COMPANY (US) 1994-02-17 WO disclosed
US-5256487-A High char yield silazane derived preceramic polymers and cured compositions thereof THE B. F. GOODRICH COMPANY (US) 1993-10-26 US disclosed